8-(1-Hydroxy-ethyl)-2-methoxy-3-(4-methoxy-benzyloxy)-benzo[c]chromen-6-one | |
---|---|
Trade Name | |
Orphan Indication | Glioblastoma |
USA Market Approval | USA |
USA Designation Date | 2015-01-21 00:00:00 |
Sponsor | Diffusion Pharmaceuticals, Inc.;2020 Avon Court, Suite 4;Charlottesville, Virginia, 22902 |